Faculty Directory

Office of the Dean Administration Departments Research Alpert Medical School Giving

Joseph Friedman, MD

Edit My Page
Joseph Friedman

Title: Professor of Neurology
Department: Neurology

Joseph_Friedman@Brown.EDU
+1 401 455 6669

Download Joseph Friedman's Curriculum Vitae in PDF Format

 
Overview | Research | Grants/Awards | Teaching | Publications

I am interested in all aspects of movement disorders. I spend most of my time seeing patients with Parkinson's disease and other movement disorders and have research interests in behavioral aspects of Parkinson's disease, particularly drug induced psychosis and fatigue. I am also interested in Huntington's disease, Machado-Joseph disease (spino cerebellar ataxia type 3), episodic ataxia type 2, as well as drug induced movement disorders.

Biography

I obtained my bachelor's degree at the University of Chicago in mathematics, master's degree in math from Washington University, MD from Columbia University College of Physicians and Surgeons, Neurology Residency at the Neurological Institute of New York, Columbia-Presbyterian Medical Center and then moved to R.I. in 1982. I pursue clincal research related to movement disorders, primarily Parksinon's disease, but also Huntington's disease, drug induced movement disorders, Machado-Joseph disease, etc.

Research Description

I have been involved in studying behavioral aspects of Parkinson's disease as my main focus. I am also interested in drug induced movement disorders, particularly those induced by antipsychotic drugs. I have been evaluating the atypical antipsychotic drugs in the treatment of drug induced psychosis in PD since 1984 and am involved, as PI of one multi center trial and as consultant in another. I have also been trying to better understand fatigue in PD, an area that has been little explored. I collaborate extensively, and am currently involved in a study of a cholinesterase inhibiting drug to improve cognitive function in non-demented PD patients. We are hoping to explore the role, if any, of diminished smell in PD patients with weight loss. We are participating in multicenter NIH funded studies evaluating the role of genetics in PD, and will be involved in clinical trials funded by the NIH of neuroprotective agents in PD, and in Huntington's disease.

Awards

1968-1969
Murphy Scholarship for Extracurricular Activities (Music). U of Chicago

1978
Harold Brown Scholarship in Tropical Medicine
Lawrence J. Durante Scholarship. Columbia University College of Physicians and Surgeons

1982-1983
"Teacher of the Year"-Elected by the Medical Housestaff, Roger Williams Medical Center

1986 & 1987
Visiting Professor, Department of Neurology, University of Vermont

1990
Honorary Member of Executive Board, Rhode Island Parkinson's Association

1990
M.A. ad eundem, Brown University

1991
Rhode Island Parkinson's Support Association Distinguished Service Award

1992
"Point of Light" award from President George Bush for volunteer work on the Traveler's Aid Medical Van

1993
Guest Editor of Rhode Island Medical Journal devoted to Movement Disorders.

1995
Co-Chair, Session on Pharmacology of Parkinson's disease, American Academy of Neurology, April, 1995, Seattle, WA.

1995
Co-Chair, Platform presentations on Neuropharmacology of Parkinson's disease. American Academy of Neurology Annual Meeting. May, 1995.

1996-1999
Member, Rhode Island Medical Society, Editorial Board of Medicine & Health/Rhode Island.

1997
Guest Editor, Health and Medicine, Rhode Island; issue devoted to stroke.

1997
Co-Chair, Platform presentations on Clozapine in movement disorders. The 4th Congress of the European Society for Clinical Neuropharmacology. December 1-4, 1997.

1998
Fellowship, American Academy of Neurology.

1999
Named in Who's Who in America, 2000 edition

2000
Accepted as life time member of National Registry of Who's Who 2000 Edition (137634)

2001
Accepted as life time member of National Registry of Who's Who 2001 Edition (137635)

2001
Accepted as a member of The National Registry of Who's Who in the World. 2001 Edition.

2001
Accepted as a member of The National Registry of Who's Who in Science and Engineering. 2001 Edition.

2001
Council on International Nontheatrical Events (CINE). Golden Eagle Award for video "EPS" 2001.

2002
Guest editor: Lancet Neurology Network

2002
Peer nomination into the book "Guide to Top Doctors," published by the Center for the Study of Services (CSS), and on the website: www.GuideToTopDoctors.org.

2002
Peer nomination into the Internet based referral service "Best Doctors". www.BestDoctors.com. February 15, 2002

2002
Friedman, JH. Recognized in "Rhode Island Monthly" May 2002 for being nominated as "Top Doc". May 2002.

2003
Chosen to be listed in The Rhode Island edition of Better Living Magazine's Best Doctors section. October 2002. www.betterlivingmagazine.com

2002
Friedman, JH. Providence Journal. Joseph H. Friedman, MD named in "Best Doctors 2001-2002". This is a database containing names of doctors from across the country chosen as "Best" by their peers. www.bestdoctors.com

2004
World Federation of Neurology Teaching Fellowship in Zambia

2004
Guest Editor, The Journal of Clinical Psychiatry, devoted to Drug-Induced Movement Disorders (Volume 65; Supplement 9)

2004
Dean's Teaching Excellence Award, Brown University Medical School

2004
NIH ad hoc peer reviewer for grant submission on Coenzyme Q10 for Early Parkinson's disease. August 9, 2004

2004
Gold Eagle Award from CINE for videotape Recognizing Parkinsonism, made with John Armstrong, Margaret Lannon.

2005
Selected as one of "America's Top Physicians" in the 'Guide to America's Top Physicians'

2005
Selected as one of Leading Health Professionals of the World. Intl Biographical Centre, Cambridge, England.

Affiliations

Rhode Island Medical Society
Rhode Island Neurological Society
American Academy of Neurology
American Neurological Association
Movement Disorders Society

Funded Research

NIH, pharmaceutical companies

Teaching Experience

I supervise Neurology residents rotating through the Movement Disorders Center. I also teach medical students in NS 262. Geriatric Internal Medicine fellows also rotate through our PD and movement disorders clinic. Brown medical students may rotate with us on their longitudinal rotation. I have been the director of Neurology Grand Rounds at Brown since their inception.

View My Full Publication List in pdf format

Selected Publications

  • Chou K, de Castillo Moro M, Friedman JH. Parkinsonian side effects of atypical antipsychotics in the elderly. Primary Care Psychiatry. In Press.(IN PRESS)
  • Murphy M, Friedman JH, Factor SA, Tetrud J. Atypical presentations of common disorders misdiagnosed as progressive supranuclear palsy (PSP). J Neurology. In press.(IN PRESS)
  • Scoggan KA, Friedman JH, Bulman DE. CACNA1A mutation in an EA-w patient responsive to acetazolamide and valproic acid. Can J Neurosci. In Press.(IN PRESS)
  • Borek L, Friedman JH. L-Dopa abuse in a patient with Parkinson's disease. Neurology. In Press(IN PRESS)
  • Chou K, Friedman JH. Symptoms of drug induced psychosis in Parkinson's disease. Clin Neuropharmacol. In Press.(IN PRESS)
  • Friedman JH, Treischmann ME, Myers RH, Fernandez HH. Monzygotic twins discordant for Huntington's disease after seven years. Arch Neurol 2005;62:995-997.(2005)
  • D'Abreu A, Friedman J, Coskun J. Non-movement herald symptoms of Machado Joseph Disease (SCA 3). Mov Disord. 2005;20:739-41(2005)
  • Friedman JH, Treischmann ME, Myers RH, Fernandez HH. Monzygotic twins discordant for Huntington's disease after seven years. Arch Neurol 2005;62:995-997.(2005)
  • Fernandez HH, Friedman JH, Lansang CM, Factor SA, et al. Diabetes mellitus among parkinsonian patients treated chronically with clozapine. Parkinsonism Rel Disord 2004;10:439-41. .(2004)
  • Fernandez HH, Trieschmann ME, Friedman JH. Aripiprazole for Drug-Induced Psychosis in Parkinson Disease: Preliminary Experience. Cln Neuropharmacol 2004;27(1):4-5.(2004)
  • Friedman JH, Fernandez HH, Trieschmann MM. Parkinsonism in a Nursing Home: Underrecognition. J Geriatr Psychiatry Neurol 2004;17(1):39-41.(2004)
  • Al-Yacoub M, Fernandez HH, Friedman JH. Hemiballism from a parietal stroke in a patient with Parkinson's disease. Mov Disord 2004;19:986-988.(2004)
  • Ready R, Friedman J, Grace J et al. Testosterone deficiency and fatigue in Parkinson's disease. J Neurol Neurosurg & Psychiatry. 2004;75:1323-26.(2004)
  • Stern MB, Marek K, Friedman JH, et al. Double-blind, Randomized, Controlled Trial of Rasagiline as Monotherapy in Early Parkinson's Disease Patients. Mov Disord 2004;19(8):916-923(2004)
  • Fernandez HH, Donnelly EM, Friedman JH. Long term outcome of clozapine use for psychosis in Parkinson's disease. Mov Disord 2004;19:831-3(2004)
  • Fernandez HH, Lannon MC, Trieschmann ME, Friedman JH. Botulinum toxin type B for gait freezing in Parkinson's disease. Med Sci Monit 2004 Jul;10(7): CR 282-4. Epub 2004. June 29(2004)
  • Fernandez HH, Friedman JH. Classification And Treatment of Tardive Syndromes. The Neurologist 2003;9:16-27.(2003)
  • Fernandez HH, Trieschmann ME, Burke MA, Jacques C, Friedman JH. Long-Term Outcome of Quetiapine Use for Psychosis Among Parkinsonian Patients. Movement Dis 2003;18:510-514.(2003)
  • Fernandez HH, Trieschmann ME, Friedman JH. Treatment of Psychosis in Parkinson's Disease. Safety Considerations. Drug Safety 2003:26:643-659.(2003)
  • Fernandez HH, Trieschmann ME, Friedman JH. Treatment of Psychosis in Parkinson's Disease. Safety Considerations. Drug Safety 2003:26:643-659.(2003)
  • Factor SA, Feustel PJ, Friedman JH, et al. Longitudinal outcome of Parkinson's disease patients with psychosis. Neurology 2003;60:1576-61.(2003)
  • Garber CE, Friedman JH. Effects of fatigue on physical activity and function in patients with Parkinson's disease. Neurology 2003;60:119-1124.(2003)
  • Walker RH, Friedman JH, Wiener J, et al. A family with tau P301L mutation presenting with Parkinsonism. Parkinsonism & Related Disorders 2002; 9:121-123.(2002)
  • Zawacki TM., Grace J., Friedman JH., Sudarsky L. Executive and Emotional Dysfunction in Machado-Joseph Disease. Movement Disorders 2002;17:1004-1010.(2002)
  • Friedman, JH et al. Stroke induced by gamma knife pallidotomy: Autopsy result. Neurology 2002;58:1695-1697(2002)
  • Fernandez HH., Trieschmann ME, Burke, MA, Friedman JH. Quetiapine for Psychosis in Parkinson's Disease Versus Dementia With Lewy Bodies. J Clin Psychiatry 2002; 63: 513-515.(2002)
  • Friedman, JH. Presumed Rapid Eye Movement Sleep Behavior Disorder in Machado-Joseph Disease (Spinocerebellar Ataxia 3). Mov Disord 2002;17:1350-1353.(2002)
  • Friedman JH, Fernandez HH. Atypical antipsychotics in Parkinson-sensitive populations. J Geriatr Psychiatry Neurol. 2002;15(3):156-70(2002)
  • Breier A, Sutton VK, Feldman PD, Kadam DL, Ferchland I, Wright P, Friedman JH. Olanzapine in the treatment of dopamimetic-induced psychosis in patients with Parkinson's disease. Biol Psychiatry 2002;52:438-45.(2002)
  • Cahn-Weiner DA, Grace J, Ott BR, Fernandez, HH, Friedman, JH. Cognitive and Behavioral Features Discriminate Between Alzheimer's and Parkinson's Disease. Neuropsychiatry, Neurology, and Behavioral Neurology, 2002;15:79-87.(2002)
  • Breier A, Sutton VK, Feldman PD, Kadam DL, Ferchland I, Wright P, Friedman JH. Olanzapine in the treatment of dopamimetic-induced psychosis in patients with Parkinson's disease. Biol Psychiatry 2002;52:438-45.(2002)
  • Cahn-Weiner DA, Grace J, Ott BR, Fernandez, HH, Friedman, JH. Cognitive and Behavioral Features Discriminate Between Alzheimer's and Parkinson's Disease. Neuropsychiatry, Neurology, and Behavioral Neurology, 2002;15:79-87.(2002)
  • Brin, MF., Lyones, KE., Doucette, J., Adler, CH., Caviness, JN., Comella, CL., Dubinsky, RM., Friedman, JH. et al. A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor. Neurology 2001;56:1523-1528.(2001)
  • Friedman, JH. Permanent Cerebellar Toxicity of Cytosine Arabinoside (Ara C) in a Young Woman. Mov Disord 2001; 16: 575-577(2001)
  • Goldstein S, Friedman JH, Marek K, et al. Hemiparkinsonism Due to a Midbrain Arteriovenous Malformation: Dopamine Transporter Imaging. Mov Disord 2001;16(2):350-375.(2001)
  • Fernandez, H., Krupp, B., Friedman, JH. The course of tardive dyskinesia and parkinsonism in psychiatric inpatients: 14-year follow-up. Neurology 2001; 56:805-807.(2001)
  • Fernandez H., Rowena EJ., Tabamo,MD., David RR., Friedman JH. Predictors of Depressive Symptoms Among Spouse Caregivers in Parkinson's Disease. Movement Disorders 2001;16:1123-1125(2001)
  • Fernandez H., Friedman JH., Fischman, A., Noto, R., Lannon, MC. Is Altropane SPECT More Sensitive to FluoroDOPA PET for Detecting Early Parkinson's Disease? Altropane SPECT versus FluoroDOPA PET in Parkinson's disease. Med Sci Monit, 2001;7:2-6.(2001)
  • Friedman, JH, Fernandez HH. Autopsy follow-up of a patient with schizophrenia and presumed idiopathic Parkinson's disease. Clinical Neuropharmacology 2001 24;(2):120-121.(2001)
  • Factor SA, Friedman JH, Lannon MC, Oakes D, Bourgeois K, and the Parkinson Study Group. Clozapine for the treatment of drug-induced psychosis in Parkinson's disease: results of the 12-week open label extension in the PSYCLOPS trial. Movement Disorders 2001 Jan: 16 (1): 135-139.(2001)
  • Friedman, JH, Friedman, H. Fatigue in Parkinson's Disease: A Nine-Year Follow-Up. Movement Disorders 2001;16:1120-1122(2001)
  • Fernandez H., Rowena EJ., Tabamo,MD., David RR., Friedman JH. Predictors of Depressive Symptoms Among Spouse Caregivers in Parkinson's Disease. Movement Disorders 2001;16:1123-1125(2001)
  • Friedman, JH, Friedman, H. Fatigue in Parkinson's Disease: A Nine-Year Follow-Up. Movement Disorders 2001;16:1120-1122(2001)
  • Fernandez H., Friedman JH., Fischman, A., Noto, R., Lannon, MC. Is Altropane SPECT More Sensitive to FluoroDOPA PET for Detecting Early Parkinson's Disease? Altropane SPECT versus FluoroDOPA PET in Parkinson's disease. Med Sci Monit, 2001;7:2-6.(2001)
  • Friedman, JH, Fernandez HH. Autopsy follow-up of a patient with schizophrenia and presumed idiopathic Parkinson's disease. Clinical Neuropharmacology 2001 24;(2):120-121.(2001)
  • Factor SA, Friedman JH, Lannon MC, Oakes D, Bourgeois K, and the Parkinson Study Group. Clozapine for the treatment of drug-induced psychosis in Parkinson's disease: results of the 12-week open label extension in the PSYCLOPS trial. Movement Disorders 2001 Jan: 16 (1): 135-139.(2001)
  • Zawacki T, Friedman JH, Grace J, Shetty N. Cerebellar toxicity of cytosine arabinoside: Clinical and neuropsychological signs. Neurology 2000 (Clinical/Scientific Notes) 55; (8): 1234(2000)
  • Fernandez HH, Friedman, JH, Famiglietti EV. Probable Cornelia de Lange Syndrome With Progressive Parkinsonism and Dystonia. Movement Disorders 2000 (Clinical/Scientific Notes) 15;(4): 749-751(2000)
  • Tabamo REJ, Fernandez HH, Friedman JH, Simon DK. Young-Onset Parkinson's Disease: A Clinical Pathologic Description of Two Siblings. Movement Disorders 2000 (Clinical/Scientific Notes) 15;(4):744-746(2000)
  • Fernandez HH, Lannon MC, Friedman JH, Abbott BP. Clozapine Replacement by Quetiapine for the Treatment of Drug-Induced Psychosis in Parkinson's Disease. Movement Disorders 2000 (Clinical/Scientific Notes) 15; (3):579-586(2000)
  • Fernandez HH, Lapane KL, Ott BR, Friedman, JH. Gender Differences in the Frequency and Treatment of Behavior Problems in Parkinson's Disease. Movement Disorders 2000; 15:(3) 490-496(2000)
  • Friedman JH, Factor SA. Atypical Antipsychotics in the Treatment of Drug-Induced Psychosis in Parkinson's Disease. Movement Disorders 2000; 15(2):201-211(2000)
  • Fernandez HH, Friedman JH, Grace J, Beason-Hazen, S. Donepezil for Huntington's Disease Movement Disorders 2000; 15: 173-175(2000)
  • Friedman JH, Fernandez HH. The Nonmotor Problems of Parkinson's Disease. The Neurologist 2000; 6: (1) 18-27(2000)
  • Fernandez HH, Lannon MC, Friedman JH, Abbott BP. Clozapine Replacement by Quetiapine for the Treatment of Drug-Induced Psychosis in Parkinson's Disease. Movement Disorders 2000 (Clinical/Scientific Notes) 15; (3):579-586(2000)
  • Fernandez HH, Lapane KL, Ott BR, Friedman, JH. Gender Differences in the Frequency and Treatment of Behavior Problems in Parkinson's Disease. Movement Disorders 2000; 15:(3) 490-496(2000)
  • Friedman JH, Factor SA. Atypical Antipsychotics in the Treatment of Drug-Induced Psychosis in Parkinson's Disease. Movement Disorders 2000; 15(2):201-211(2000)
  • Friedman JH, Fernandez HH. The Nonmotor Problems of Parkinson's Disease. The Neurologist 2000; 6: (1) 18-27(2000)
  • Fernandez HH, Friedman JH, Grace J, Beason-Hazen, S. Donepezil for Huntington's Disease Movement Disorders 2000; 15: 173-175(2000)
  • Tabamo REJ, Fernandez HH, Friedman JH, Simon DK. Young-Onset Parkinson's Disease: A Clinical Pathologic Description of Two Siblings. Movement Disorders 2000 (Clinical/Scientific Notes) 15;(4):744-746(2000)
  • Fernandez HH, Friedman JH. Punding on L-DOPA. Mov Disorders 1999; 14:836-838.(1999)
  • Fernandez HH, Friedman JH. Atypical antipsychotics in movement disorder patients. CNS Drugs. 1999; 11(6):467-483.(1999)
  • Rosenfeld M, Friedman JH. Catatonia Responsive to Lorazepam.Mov Dis. 1999;14(1):161-162.(1999)
  • Lapane K, Fernandez HH, Friedman JH. And The SAGE Study Group. Prevalence, Clinical Characteristics, and Pharmacologic Treatment of Parkinson's Disease in Residents in Long-Term Care Facilities. Pharmacoepidemiology 1999; 19:1321-1327(1999)
  • Parkinson Study Group (Joseph H. Friedman first author). Low Dose Clozapine for The Treatment of Drug-Induced Psychosis In Parkinson's Disease. N Eng J med 1999; 340:757-763.(1999)
  • Myers DL, Arya LA, Friedman JH. Is Urinary Incontinence Different in Women with Parkinson's Disease? Int Urogynecology Journal 1999; 53:438-439.(1999)
  • Shetty N, Friedman JH, Kieburtz K, et al. The Placebo Response in Parkinson's Disease. Clinical Neuropharmacology 1999; (22):207-212.(1999)
  • Lapane K, Fernandez HH, Friedman JH. And The SAGE Study Group. Prevalence, Clinical Characteristics, and Pharmacologic Treatment of Parkinson's Disease in Residents in Long-Term Care Facilities. Pharmacoepidemiology 1999; 19:1321-1327(1999)
  • Parkinson Study Group (Joseph H. Friedman first author). Low Dose Clozapine for The Treatment of Drug-Induced Psychosis In Parkinson's Disease. N Eng J med 1999; 340:757-763.(1999)
  • Myers DL, Arya LA, Friedman JH. Is Urinary Incontinence Different in Women with Parkinson's Disease? Int Urogynecology Journal 1999; 53:438-439.(1999)
  • Shetty N, Friedman JH, Kieburtz K, et al. The Placebo Response in Parkinson's Disease. Clinical Neuropharmacology 1999; (22):207-212.(1999)
  • Pickett ER, Kuniholm E, Protopapas A, Friedman JH, Lieberman P. Selective speech motor, syntax and cognitive deficits associated with bilateral damage to the putamen and the head of the caudate nucleus: a case study. Neuropsychologia 1998;36(2):173-188.(1998)
  • Friedman JH, Goldstein S, Jacques C. Substituting Olanzapine for Clozapine. Clin Neuropharmacol.1998;21(5):285-288.(1998)
  • Friedman JH. Behavioral Dysfunction in Parkinson's Disease. Clinical Neuroscience Volume1998;5:87-93.(1998)
  • Fernandez HH, Friedman JH, Jacques C, Rosenfeld M. Quetiapine for the Treatment of Drug-Induced Psychosis in Parkinson's Disease. Mov Dis 1998;14(3):484-487.(1998)
  • Growdon JH, Kieburtz K, McDermott MP, Panisset M, Friedman JH. Levodopa improves motor function without impairing cognition in mild non-demented Parkinson's disease patients. Neurology 1998; 50 (5): 1327-31.(1998)
  • Trosch RM, Friedman JH, O'Brien C, et al. Clozapine Use in Parkinson's disease: a retrospective analysis of a large multi centered clinical experience. Movement Disorders. 1998; (13): 377-382.(1998)
  • Goren JL, Friedman JH. Yawning as an aura for an L-Dopa induced "on" in Parkinson's disease. Neurology. 1998; (50):823.(1998)
  • Friedman JH. Behavioral Dysfunction in Parkinson's Disease. Clinical Neuroscience Volume1998;5:87-93.(1998)
  • Fernandez HH, Friedman JH, Jacques C, Rosenfeld M. Quetiapine for the Treatment of Drug-Induced Psychosis in Parkinson's Disease. Mov Dis 1998;14(3):484-487.(1998)
  • Growdon JH, Kieburtz K, McDermott MP, Panisset M, Friedman JH. Levodopa improves motor function without impairing cognition in mild non-demented Parkinson's disease patients. Neurology 1998; 50 (5): 1327-31.(1998)
  • Trosch RM, Friedman JH, O'Brien C, et al. Clozapine Use in Parkinson's disease: a retrospective analysis of a large multi centered clinical experience. Movement Disorders. 1998; (13): 377-382.(1998)
  • Goren JL, Friedman JH. Yawning as an aura for an L-Dopa induced "on" in Parkinson's disease. Neurology. 1998; (50):823.(1998)
  • Friedman JH. Machado-Joseph Disease/SCA3 responsive to Buspirone. Movement Disorders 1997;12 (4):613-614.(1997)
  • Factor SA, Friedman JH. The emerging use of clozapine in the treatment of patients with movement disorders. Movement Disorders 1997;12 (4):483-496.(1997)
  • Shannon, KM, Bennett JP, Friedman JH: Efficacy of pramipexole, a novel dopamine agonist as monotherapy in mild to moderate Parkinson's disease. Neurology, 1997 49; (3):724-728.(1997)
  • Lieberman A, Ranhowsky A, Korts, D, et al. Clinical evaluation of pramipexole in advanced Parkinson's disease: results of a double-blind, placebo-controlled, parallel-group study. Neurology July 1997;49(1):162-168.(1997)
  • Friedman JH, Koller WC, Lannon MC, Benzotropine versus Clozapine for the treatment of tremor in Parkinson's disease. Neurology 1997;4(48):1077-1081.(1997)
  • Shannon, KM, Bennett JP, Friedman JH: Efficacy of pramipexole, a novel dopamine agonist as monotherapy in mild to moderate Parkinson's disease. Neurology, 1997 49; (3):724-728.(1997)
  • Lieberman A, Ranhowsky A, Korts, D, et al. Clinical evaluation of pramipexole in advanced Parkinson's disease: results of a double-blind, placebo-controlled, parallel-group study. Neurology July 1997;49(1):162-168.(1997)
  • Friedman JH, Koller WC, Lannon MC, Benzotropine versus Clozapine for the treatment of tremor in Parkinson's disease. Neurology 1997;4(48):1077-1081.(1997)
  • Mikolivich DJ, Kinsella LH, Skowron G, Friedman JH, Sugar AM, et al. Aspergillus meningitis in an immunocompetent adult successfully treated with itraconazole. Clin Inf Dis 1996;23(6):1318-9.(1996)
  • Friedman JH, Epstein M, Sanes J, Lieberman P, Cullen K, Lindquist C, Daamen M. Gamma Knife Pallidotomy in Advanced Parkinson's Disease. Ann Neurol 1996;39:535-538.(1996)
  • Friedman J, Westlake R, Furman M: "Grievous Bodily Harm": Gamma Hydroxybutyrate Abuse Leading to a Wernicke-Korsakoff Syndrome. Neurology 1996;46(2):469-471.(1996)
  • Friedman JH. Walking-Induced Parkinsonism Due to Presumed Idiopathic Normal Pressure Hydrocephalus. Movement Disorders 1996;ll(1):99-101.(1996)
  • Rich S, Friedman JH, Ott BR. Risperidone versus clozapine in the treatment of psychosis in Parkinson's patients. J Clin Psychiatry 1995;56(12):556-569.(1995)
  • Rich S, Friedman JH, Ott BR. Risperidone versus clozapine in the treatment of psychosis in Parkinson's patients. J Clin Psychiatry 1995;56(12):556-569.(1995)
  • Hubble JP, Koller WC, Cutler NR, Sramek JJ, Friedman J et al: Pramipexole in Patients with Early Parkinson's Disease. Clin Neuropharmacol. 1995;18:338-347.(1995)
  • Friedman JH. Clozapine treatment of psychosis in patients with tardive dystonia: Report of three cases. Movement Disorders 1994;9(3):321-324.(1994)
  • Friedman JH, Weitberg A: Ataxia Without Telangiectasia. Movement Disorders 1993;8:223-226.(1993)
  • Friedman JH, Friedman H: Fatigue in Parkinson's Disease. Neurology 1993;43:2016-2018.(1993)
  • Friedman JH, Caley C: Does fluoxetine exacerbate Parkinson's disease? J. Clin Psychiatry 1992;53:278-282.(1992)
  • Lieberman P, Friedman JH, Feldman LS: Speech Production, Syntax Comprehension and Cognitive Deficits in Parkinson's Disease. Brain and Language 1992;43(2):169-189.(1992)
  • Pueschl S, Friedman JH, Shetty T: Myoclonic Dystonia. Child Nervous System 1992;8(2):61-66.(1992)
  • Friedman JH, Gordon N. ECT in Parkinson's Disease. Convulsive Therapy 1992;8(3):204-210.(1992)
  • Friedman JH: Rubral tremor induced by neuroleptic. Movement Disorders 1992;7 (3):281-282.(1992)
  • McKnight P, Friedman JH. Torticollis in an adult due to cervical epidural abscess. Neurology 1992;42:696-697.(1992)
  • Friedman JH, Ambler M: Progressive Parkinsonism Associated With Rosenthal Fibers: Senile Onset Alexander's Disease. Neurology 1992;42:1733-1735.(1992)
  • Friedman JH: The Management of the Levodopa Psychoses. Clinical Neuropharmacology 1991;14 (4):283-295. Review(1991)
  • Friedman JH: Drug induced movement disorders. Hospital Pharmacy. 1991;26:524-530.(1991)
  • Rafal R, Friedman JH: Rostral Basilar Reversible Ischemic Neurologic Deficit in an HIV Infected Patient with Cryptococcal Meningitis. Am J Med 1990;89(2):248-249.(1990)
  • Friedman JH: Primary Movement Disorders. RI Med J 1990;73 (2):69-73.(1990)
  • Friedman JH, Ambler M: A Case of Senile Chorea. Movement Disorders 1990;5(3):251-253.(1990)
  • Lieberman P, Friedman JH, Feldman LS: Syntax Comprehension Deficits in Parkinson's Disease. J Nervous and Mental Dis. 1990;178(6):360-365.(1990)
  • Friedman JH, Lannon MC: Clozapine-responsive tremor in Parkinson's disease. Movement Disorders 1990;5(3):225-229.(1990)
  • Friedman JH: Progressive Parkinsonism in Boxers. Southern Medical Journal 1989;82(5):543-546.(1989)
  • Sandson T, Friedman JH: Spinal Cord Infarction. Report of Eight Cases and Review of the Literature. Medicine 1989;68:282-292.(1989)
  • Friedman JH, Levy HL, Boustany R: Late Onset of Distinct Neurologic Syndromes in Galactosemic Siblings. Neurology 1989;39(5):741-742.(1989)
  • Rafal RD, Friedman JH, Lannon MC: Preparation of Manual Movements in Hemiparkinsonism. J Neurol Neurosurg & Psychiatry 1989;52 (3):399-402.(1989)
  • Friedman JH Lannon MC: Clozapine for the treatment of psychosis in Parkinson's Disease. Neurology 1989;39 (9):1219-1221.(1989)
  • Friedman JH, Lannon MC: An Open Trial of Controlled Release Carbidopa/L-DOPA (CR4 Sinemet) For the Treatment of Mild to Moderate Parkinson's Disease. Clinic Neuropharm. 1989;12(3):220-223.(1989)
  • Tzelepis GE, McCool FD, Friedman JH, Hoppin FG: Respiratory Muscle Dysfunction in Parkinson's Disease. Am Rev Resp Dis 1988;138 (3):266-271.(1988)
  • Friedman JH: Azorean Disease (Joseph/Machado Disease) . RI Med J 1988;71(4):149-153.(1988)
  • Rafal RD, Posner M, Friedman JH, Inhoff AW, Bernstein E: Orienting of visual attention in progressive Supranuclear Palsy. Brain 1988;111(Pt 2):267-280.(1988)
  • Friedman JH, Davies RL, Wagner RL: Neuroleptic Malignant Syndrome: The Results of a Six Month Prospective Study of Incidence in a State Psychiatric Hospital. Clin Neuropharm 1988;2(4):373-377(1988)
  • Friedman JH, Max J, Swift R: Idiopathic Parkinson's Disease in a Chronic Schizophrenic: Long Term Treatment with Clozapine and L-DOPA. Clin Neuropharm. 1987;10(5):470-475.(1987)
  • Rafal RD, Inhoff AW, Friedman JH, Bernstein E: Programming and complex motor sequences in Parkinson's Disease. J Neurol Neurosurg and Psychiatry 1987;50:1267-1273.(1987)
  • Kucharski LT, Friedman JH, Wagner RL: An investigation of the coexistence of abnormal involuntary movements, parkinsonism and akathisia in chronic psychiatric inpatients. Psychopharmacology Bulletin 1987;23(l):215-217.(1987)
  • Friedman JH, Kucharski TL, Wagner RL: Tardive Dystonia in a Psychiatric Hospital. J. Neurol Neurosurg & Psychiatry 1987;50:801-803.(1987)
  • Friedman JH, Hollmann PA: Acetazolamide Responsive Hereditary Paroxysmal Ataxia. Movement Disorders 1987;2(l):67-72.(1987)
  • Friedman JH: Hemifacial Gustatory sweating Due To a Pancoast Tumor. Am J Med 1987;82:1269-1273.(1987)
  • Friedman JH, Chuicchini I, Tucci J: Idiopathic Hypoparathyroidism with Extensive Brain Calcification and Persistent Neurologic Dysfunction. Neurology 1987;37:307-309.(1987)
  • Friedman JH, Wagner RL: Akathisia: The syndrome of motor restlessness. American Family Physician 1987;35(2):145-149.(1987)
  • Rafal RD, Friedman JH: Limb Dystonia in Progressive Supranuclear Palsy. Neurology 1987;37:1546-1549.(1987)
  • Friedman JH: Recent Research Advances in Parkinson's Disease, Part II: Brain Implantation Therapy. RI Med J 1986;69(8):361-363.(1986)
  • Friedman JH: Recent Research Advances in Parkinson's Disease. Part I: MPTP. RI Med J 1986;69(7)319-322.(1986)
  • Friedman JH: A case of progressive hemichorea responsive to high dose reserpine. J Clin Psychiatry 1986;47:149-150.(1986)
  • Friedman JH: Syndrome of diffuse encephalopathy due to non-dominant thalamic infarction. Neurology 1985;35:1524-1526.(1985)
  • Friedman JH, Feinberg S, Feldman RD: A neuroleptic malignant like syndrome due to L-DOPA withdrawal. JAMA 1985;254:2792-2795(1985)
  • Lally E, Friedman JH, Kaplan S: Progressive myalgias and polyarthralgias in a patient with myoadenylate deaminase deficiency. Arthritis and Rheumatism 1985;28:1298-1302.(1985)
  • Friedman JH: Drug holidays in Parkinson's Disease: A brief review. Arch Int. Med 1985;145:913-915.(1985)
  • Weinstein R, Herec D, Friedman JH: Hypotension due to glossopharyngeal neuralgia. Arch Neurol 1985;43:90-92.(1985)
  • Burke RE, Fahn S, Marsden CD, Bressman SB, Moskowitz C, and Friedman JH: Validity and reliability of a rating scale for the primary torsion dystonias. Neurology 1985;35:73-77.(1985)
  • Friedman J, Brem H, Mayeux R: Global aphasia in multiple sclerosis. Ann Neurol 1983;13:222-223.(1983)
  • Haruda F, Friedman J, Ganti S, Hoffman N, Chutorian A: Reversal of organic mental syndrome in sickle cell anemia by rapid exchange transfusion. Neurology 1981;31:1015-1016.(1981)
  • Friedman JH: Controversies in the Treatment of Parkinson's Disease. RI Med J 1981;68:461-463.(1981)
  • Friedman J, Brust J, Challenor Y: Bilateral facial palsy associated with Steven-Johnson Syndrome. Neurology 1979;29:1304-1306.(1979)
  • Schultz G, Barry C, Friedman J, et al: Comparison of predicted and experimentally determined secondary structure of adenylate kinase. Nature 1974;250:140-142.(1974)